Menivim REIT: How Self-Funded the Growth Wave Really Is

The main article argued that Menivim enters 2026 with a stable core, but with a funding test sitting underneath the expansion story. This follow-up isolates that question only: how much of the growth wave is really financed by internal cash generation after dividends, debt service and property investment, rather than before them.

The answer depends on two different cash pictures, and mixing them leads to the wrong conclusion. On a normalized / maintenance cash generation view, the existing business looks healthy: real FFO of NIS 173.1 million and cash flow from operations of NIS 204.5 million. On an all-in cash flexibility view, the picture changes sharply. After NIS 188.4 million of investment, NIS 98.8 million of dividends, NIS 40.1 million of interest and NIS 79.3 million of bond repayments, 2025 was negative by NIS 202.1 million before external funding sources.

That number matters because the year still ended with a NIS 60.0 million rise in cash. That increase did not come only from the asset base. It also came from NIS 152.1 million of cash received from Series 4 warrant exercises and about NIS 110.0 million net from bond issuance. In other words, Menivim is not facing a liquidity squeeze, but based on 2025 evidence its growth wave was not funded only by the cash coming out of the current portfolio.

Two Cash Pictures, and Only One of Them Answers the Real Funding Question

The right way to read Menivim is to separate the business layer from the layer of all actual cash uses.

That is the key point. Menivim does not disclose maintenance CAPEX separately, so there is no clean way to build a narrow "post-maintenance" internal cash bridge. What can be said with confidence is more limited but still important: the existing business generates healthy cash, but 2025 was not a year in which that cash also funded the full expansion wave and the full distribution burden.

2025: Operating Cash Funded the Business, Not the Whole Year

If you stop at the operating layer, it is easy to see why Menivim looks strong. Cash flow from operations rose to NIS 204.5 million, above real FFO, and management explicitly attributes the improvement mainly to higher NOI. That is a solid base.

But the picture changes quickly once all the uses that already happened are brought in. Dividends paid in 2025 came to NIS 98.8 million, interest paid on the bonds came to NIS 40.1 million, and scheduled bond principal repayments came to NIS 79.3 million. Those three items alone add up to NIS 218.2 million. That means even before property investment, the year's operating cash flow did not fully cover dividends, interest and scheduled debt service together.

The exact arithmetic matters. After dividends and interest, the company had about NIS 65.6 million left. After bond repayments, it was already in a cash deficit of about NIS 13.7 million, before a single shekel of property investment. Once the NIS 188.4 million investment outflow is added, the deficit before external funding reaches about NIS 202.1 million.

That chart makes clear why the rise in cash to NIS 195.1 million at year-end does not prove Menivim funded the expansion on its own. It shows the opposite. The cash increase exists only after two large external sources are added: NIS 152.1 million from warrant exercises and about NIS 110.0 million net from bond issuance.

This is not a footnote. Without those two sources, 2025 would not have ended with more cash. It would have ended with a sharp cash draw. That is why looking only at FFO or only at cash flow from operations produces the wrong answer. The core question is not whether the assets work. They do. The real question is how much of growth, distributions and debt service were already carried by external capital.

2026 Starts Without the Warrant Cushion, and with a Dividend Floor That Already Uses a Lot of the FFO

This matters now because 2025 included one source that will not repeat. By the final exercise date of 7 December 2025, 87,320,668 Series 4 warrants had been exercised, bringing in about NIS 152.1 million of cash. Another 432 warrants expired without value. Put simply, that warrant cushion does not exist in 2026.

At the same time, the company says explicitly that future activity will be financed through additional equity raises, bond issuance and loans from institutional and banking sources. That wording matters because it makes clear that management itself is not framing the next phase as one funded only by the current portfolio.

The 2026 guidance reinforces the point. Management guides to NOI of NIS 251 million to NIS 254 million, real FFO of NIS 175 million to NIS 177 million, and a minimum dividend of NIS 111 million. In other words, the dividend floor alone equals roughly 62.7% to 63.4% of guided real FFO, before interest, debt repayments or new investment.

That does not mean the dividend is too high. It means something narrower and more important: if 2026 is supposed to include continued acquisitions, debt service and a minimum dividend, it becomes harder to argue that the company has already shifted into a fully internally funded growth phase simply because the guided FFO number looks healthy.

The immediate post-balance-sheet steps make the same point. In January 2026 the company expanded Series D for gross proceeds of about NIS 336.9 million, and around that move it carried out a partial early redemption of Series B in February for NIS 246.2 million. That is a liability-management improvement, but it is also a reminder that a large part of the early-2026 financing move is not "free" new cash firepower. It is refinancing and reshaping existing debt layers.

Then in March 2026 Midroog assigned a stable Aa3.il rating to a new Series E of up to NIS 400 million, with proceeds intended for the company's ongoing activity. That is another double signal. On one side, the debt market remains open. On the other side, the very need to prepare another series underlines that the growth model still relies on external funding architecture, not only on cash left over after everything else.

This Is Not a Liquidity Alarm, It Is a Funding-Architecture Story

Precision matters here. This piece is not arguing that Menivim is under immediate pressure. As of year-end 2025 the company remains comfortably inside all of its financial covenants, with large buffers.

Cash did not disappear either. The company had about NIS 195 million at year-end and about NIS 176 million by the report date. So it would be wrong to describe Menivim as a company being cornered.

But that is exactly why the question is more interesting. If the company were visibly pressured, the story would be easy. Menivim is the opposite case. It is strong enough to raise debt cheaply, refinance, extend series and keep expanding. That means the real test is not whether it can fund growth at all. It is how much of that growth is funded from within, and how much is still being borrowed forward.

That conclusion gets sharper once the layers are combined. 2025 operating cash generation was good, but it did not cover the full set of uses. The warrant source that helped the picture in 2025 is gone. And management itself is signalling that the next leg still runs through debt markets and additional funding sources. So the right claim is not that Menivim is overleveraged. It is that its growth wave is still only partly internally funded once dividends and debt service are included.

Conclusion

The correct read on Menivim is not that the company is living on the edge, but also not that it has already moved into a growth model funded entirely by the existing NOI base. At the business level, the picture is healthy. At the level of all actual cash uses, 2025 showed a gap of about NIS 202.1 million before external sources, and that gap was closed by warrants and debt.

That is the heart of the 2026 funding test. The warrant source is gone, the minimum dividend already claims a meaningful share of FFO, and management is still building the next growth phase through the debt market as well. So Menivim's funding test is not a survival test. It is a quality test: will the acquisitions and incoming assets start contributing NOI and FFO fast enough to reduce that dependence, or will the model remain structurally reliant on especially easy capital-market access.